Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β

Biochemical and Biophysical Research Communications

Volumn 443, Issue 3, 2014, Pages 950-956

  Sakata, Kotaro ^a,b,c   Eda, Satoshi ^a   Lee, Eun Seo ^a   Hara, Mitsuko ^a   Imoto, Masaya ^b   Kojima, Soichi ^a  

^a RIKEN   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Hepatic stellate cells; Liver fibrosis; Liver sinusoidal endothelial cells; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; HYDROXYPROLINE; LATENCY ASSOCIATED PEPTIDE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C; PLASMA KALLIKREIN; RECOMBINANT VASCULOTROPIN; TRANSFORMING GROWTH FACTOR BETA; UROKINASE RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL SURFACE; ENDOTHELIUM CELL; FIBROGENESIS; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; MOUSE; NEOVESSEL FORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL;

MUS;

HEPATIC STELLATE CELLS; LIVER FIBROSIS; LIVER SINUSOIDAL ENDOTHELIAL CELLS; TRANSFORMING GROWTH FACTOR-Β;

ANIMALS; CELL MEMBRANE; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; HEPATIC STELLATE CELLS; KALLIKREINS; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893693128     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.074     Document Type: Article

References (27)

1. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669
2. R. Bataller, and D.A. Brenner Liver fibrosis J. Clin. Invest. 115 2005 209 218
3. N.C. Henderson, T.D. Arnold, Y. Katamura, M.M. Giacomini, J.D. Rodriguez, J.H. McCarty, A. Pellicoro, E. Raschperger, C. Betsholtz, P.G. Ruminski, D.W. Griggs, M.J. Prinsen, J.J. Maher, J.P. Iredale, A. Lacy-Hulbert, R.H. Adams, and D. Sheppard Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs Nat. Med. 19 2013 1617 1624
4. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol. Rev. 88 2008 125 172
5. H. Tsukamoto Cytokine regulation of hepatic stellate cells in liver fibrosis Alcohol. Clin. Exp. Res. 23 1999 911 916
6. F.R. Weiner, M.A. Giambrone, M.J. Czaja, A. Shah, G. Annoni, S. Takahashi, M. Eghbali, and M.A. Zern Ito-cell gene expression and collagen regulation Hepatology 11 1990 111 117
7. M. Matsuoka, N.T. Pham, and H. Tsukamoto Differential effects of interleukin-1α, tumor necrosis factor α, and transforming growth factor β1 on cell proliferation and collagen formation by cultured fat-storing cells Liver 9 1989 71 78
8. S.B. Jakowlew, J.E. Mead, D. Danielpour, J. Wu, A.B. Roberts, and N. Fausto Transforming growth factor-β (TGF-β) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-β Cell Regul. 2 1991 535 548
9. K. Akita, M. Okuno, M. Enya, S. Imai, H. Moriwaki, N. Kawada, Y. Suzuki, and S. Kojima Impaired liver regeneration in mice by lipopolysaccharide via TNF-α/kallikrein-mediated activation of latent TGF-β Gastroenterology 123 2002 352 364
10. S. Kojima Detection of hepatic fibrogenesis targeting proteolytic TGF-β activation reaction Hepatology 2008 917A
11. D. Thabut, and V. Shah Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J. Hepatol. 53 2010 976 980
12. B.S. Ding, D.J. Nolan, J.M. Butler, D. James, A.O. Babazadeh, Z. Rosenwaks, V. Mittal, H. Kobayashi, K. Shido, D. Lyden, T.N. Sato, S.Y. Rabbany, and S. Rafii Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration Nature 468 2010 310 315
13. M. Fernandez, D. Semela, J. Bruix, I. Colle, M. Pinzani, and J. Bosch Angiogenesis in liver disease J. Hepatol. 50 2009 604 620
14. H. Sahin, E. Borkham-Kamphorst, C. Kuppe, M.M. Zaldivar, C. Grouls, M. Al-samman, A. Nellen, P. Schmitz, D. Heinrichs, M.L. Berres, D. Doleschel, D. Scholten, R. Weiskirchen, M.J. Moeller, F. Kiessling, C. Trautwein, and H.E. Wasmuth Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice Hepatology 55 2012 1610 1619
15. G.K. Reddy, and C.S. Enwemeka A simplified method for the analysis of hydroxyproline in biological tissues Clin. Biochem. 29 1996 225 229
16. S. Kitazume, R. Imamaki, K. Ogawa, Y. Komi, S. Futakawa, S. Kojima, Y. Hashimoto, J.D. Marth, J.C. Paulson, and N. Taniguchi α2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling J. Biol. Chem. 285 2010 6515 6521
17. P.K. Datta, and H.L. Moses STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling Mol. Cell. Biol. 20 2000 3157 3167
18. K. Sakata, M. Hara, T. Terada, N. Watanabe, D. Takaya, S. Yaguchi, T. Matsumoto, T. Matsuura, M. Shirouzu, S. Yokoyama, T. Yamaguchi, K. Miyazawa, H. Aizaki, T. Suzuki, T. Wakita, M. Imoto, and S. Kojima HCV NS3 protease enhances liver fibrosis via binding to and activating TGF-β type I receptor Sci. Rep. 3 2013 3243
19. S.J. Mandriota, G. Seghezzi, J.D. Vassalli, N. Ferrara, S. Wasi, R. Mazzieri, P. Mignatti, and M.S. Pepper Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells J. Biol. Chem. 270 1995 9709 9716
20. J.M. Breuss, and P. Uhrin VEGF-initiated angiogenesis and the uPA/uPAR system Cell Adh. Migr. 6 2012 535 615
21. R.W. Colman Regulation of angiogenesis by the kallikrein-kinin system Curr. Pharm. Des. 12 2006 2599 2607
22. H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, D.J. Hicklin, Y. Wu, K. Yanase, T. Namisaki, M. Yamazaki, H. Tsujinoue, H. Imazu, T. Masaki, and H. Fukui Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 52 2003 1347 1354
23. J.S. Lee, D. Semela, J. Iredale, and V.H. Shah Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 45 2007 817 825
24. D. Thabut, C. Routray, G. Lomberk, U. Shergill, K. Glaser, R. Huebert, L. Patel, T. Masyuk, B. Blechacz, A. Vercnocke, E. Ritman, R. Ehman, R. Urrutia, and V. Shah Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis Hepatology 54 2011 573 585
25. M. Mejias, E. Garcia-Pras, C. Tiani, R. Miquel, J. Bosch, and M. Fernandez Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats Hepatology 49 2009 1245 1256
26. J.M. Wood, G. Bold, E. Buchdunger, R. Cozens, S. Ferrari, J. Frei, F. Hofmann, J. Mestan, H. Mett, T. O'Reilly, E. Persohn, J. Rosel, C. Schnell, D. Stover, A. Theuer, H. Towbin, F. Wenger, K. Woods-Cook, A. Menrad, G. Siemeister, M. Schirner, K.H. Thierauch, M.R. Schneider, J. Drevs, G. Martiny-Baron, and F. Totzke PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res. 60 2000 2178 2189
27. N. Ferrara, K.J. Hillan, H.P. Gerber, and W. Novotny Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat. Rev. Drug. Discovery 3 2004 391 400 Technology